1   EXECUTIVE SUMMARY
1.1 DISEASE OVERVIEW
1.2 GLOBAL SCENARIO
1.3 COUNTRY OVERVIEW
1.4 HEALTHCARE SCENARIO IN COUNTRY
1.5 PATIENT JOURNEY
1.6 HEALTH INSURANCE COVERAGE IN COUNTRY
1.7 ACTIVE PHARMACEUTICAL INGREDIENT (API)
1.8 RECENT DEVELOPMENTS IN THE COUNTRY

2   MARKET SIZE AND FORECASTING
2.1 EPIDEMIOLOGY OF DISEASE
2.2 MARKET SIZE (WITH EXCEL & METHODOLOGY)
2.3 MARKET SEGMENTATION (CHECK ALL SEGMENTS IN SEGMENTATION SECTION)

3   MARKET DYNAMICS
3.1 MARKET DRIVERS
3.2 MARKET RESTRAINTS

4   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET - INTRODUCTION
    4.1    OVERVIEW
    4.2    MARKET DYNAMICS
    4.3    INDUSTRY TRENDS
    4.4    COMPETITIVE INTELLIGENCE

5   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET LANDSCAPE
    5.1    HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
    5.2    MARKET FORECAST (2025-2033)

6   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET - BY END USERS
    6.1    HOSPITALS
        6.1.1 OVERVIEW
        6.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        6.1.3 MARKET FORECAST (2025-2033)
    6.2    CLINICS
        6.2.1 OVERVIEW
        6.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        6.2.3 MARKET FORECAST (2025-2033)

7   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET - BY DRUG
    7.1    NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
        7.1.1 OVERVIEW
        7.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        7.1.3 MARKET FORECAST (2025-2033)
    7.2    DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
        7.2.1 OVERVIEW
        7.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        7.2.3 MARKET FORECAST (2025-2033)
    7.3    TUMOR NECROSIS FACTOR (TNF) INHIBITORS
        7.3.1 OVERVIEW
        7.3.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        7.3.3 MARKET FORECAST (2025-2033)
    7.4    INTERLEUKIN-17 (IL-17) INHIBITORS
        7.4.1 OVERVIEW
        7.4.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        7.4.3 MARKET FORECAST (2025-2033)
    7.5    BIOLOGIC DRUGS
        7.5.1 OVERVIEW
        7.5.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        7.5.3 MARKET FORECAST (2025-2033)

8   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET – BY REGION 
    8.1    KANTO REGION
        8.1.1 OVERVIEW
        8.1.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.1.3 MARKET BREAKUP BY TYPE
        8.1.4 MARKET BREAKUP BY COMPONENT
        8.1.5 KEY PLAYERS
        8.1.6 MARKET FORECAST (2025-2033)
    8.2    KINKI REGION
        8.2.1 OVERVIEW
        8.2.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.2.3 MARKET BREAKUP BY TYPE
        8.2.4 MARKET BREAKUP BY COMPONENT
        8.2.5 KEY PLAYERS
        8.2.6 MARKET FORECAST (2025-2033)
    8.3    CENTRAL/ CHUBU REGION
        8.3.1 OVERVIEW
        8.3.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.3.3 MARKET BREAKUP BY TYPE
        8.3.4 MARKET BREAKUP BY COMPONENT
        8.3.5 KEY PLAYERS
        8.3.6 MARKET FORECAST (2025-2033)
    8.4    KYUSHU-OKINAWA REGION
        8.4.1 OVERVIEW
        8.4.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.4.3 MARKET BREAKUP BY TYPE
        8.4.4 MARKET BREAKUP BY COMPONENT
        8.4.5 KEY PLAYERS
        8.4.6 MARKET FORECAST (2025-2033)
    8.5    TOHOKU REGION
        8.5.1 OVERVIEW
        8.5.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.5.3 MARKET BREAKUP BY TYPE
        8.5.4 MARKET BREAKUP BY COMPONENT
        8.5.5 KEY PLAYERS
        8.5.6 MARKET FORECAST (2025-2033)
    8.6    CHUGOKU REGION
        8.6.1 OVERVIEW
        8.6.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.6.3 MARKET BREAKUP BY TYPE
        8.6.4 MARKET BREAKUP BY COMPONENT
        8.6.5 KEY PLAYERS
        8.6.6 MARKET FORECAST (2025-2033)
    8.7    HOKKAIDO REGION
        8.7.1 OVERVIEW
        8.7.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.7.3 MARKET BREAKUP BY TYPE
        8.7.4 MARKET BREAKUP BY COMPONENT
        8.7.5 KEY PLAYERS
        8.7.6 MARKET FORECAST (2025-2033)
    8.8    SHIKOKU REGION
        8.8.1 OVERVIEW
        8.8.2 HISTORICAL AND CURRENT MARKET TRENDS (2019-2024)
        8.8.3 MARKET BREAKUP BY TYPE
        8.8.4 MARKET BREAKUP BY COMPONENT
        8.8.5 KEY PLAYERS
        8.8.6 MARKET FORECAST (2025-2033)

   9   JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET – COMPETITIVE LANDSCAPE
    9.1    OVERVIEW
    9.2    MARKET STRUCTURE
    9.3    MARKET PLAYER POSITIONING
    9.4    TOP WINNING STRATEGIES
    9.5    COMPETITIVE DASHBOARD
    9.6    COMPANY EVALUATION QUADRANT

10  PROFILES OF KEY PLAYERS
    10.1    ABBVIE 
        10.1.1 BUSINESS OVERVIEW
        10.1.2 SERVICES OFFERED
        10.1.3 BUSINESS STRATEGIES
        10.1.4 SWOT ANALYSIS
        10.1.5 MAJOR NEWS AND EVENTS
    10.2    AMGEN
        10.2.1 BUSINESS OVERVIEW
        10.2.2 SERVICES OFFERED
        10.2.3 BUSINESS STRATEGIES
        10.2.4 SWOT ANALYSIS
        10.2.5 MAJOR NEWS AND EVENTS
    10.3    ELI LILLY
        10.3.1 BUSINESS OVERVIEW
        10.3.2 SERVICES OFFERED
        10.3.3 BUSINESS STRATEGIES
        10.3.4 SWOT ANALYSIS
        10.3.5 MAJOR NEWS AND EVENTS
    10.4    JANSSEN 
        10.4.1 BUSINESS OVERVIEW
        10.4.2 SERVICES OFFERED
        10.4.3 BUSINESS STRATEGIES
        10.4.4 SWOT ANALYSIS
        10.4.5 MAJOR NEWS AND EVENTS
    10.5    MERCK
        10.5.1 BUSINESS OVERVIEW
        10.5.2 SERVICES OFFERED
        10.5.3 BUSINESS STRATEGIES
        10.5.4 SWOT ANALYSIS
        10.5.5 MAJOR NEWS AND EVENTS
    10.6    PFIZER
        10.5.1 BUSINESS OVERVIEW
        10.5.2 SERVICES OFFERED
        10.5.3 BUSINESS STRATEGIES
        10.5.4 SWOT ANALYSIS
        10.5.5 MAJOR NEWS AND EVENTS
    10.7    NOVARTIS
        10.5.1 BUSINESS OVERVIEW
        10.5.2 SERVICES OFFERED
        10.5.3 BUSINESS STRATEGIES
        10.5.4 SWOT ANALYSIS
        10.5.5 MAJOR NEWS AND EVENTS

11  JAPAN ANKYLOSING SPONDYLITIS THERAPEUTICS MARKET - INDUSTRY ANALYSIS
    11.1    DRIVERS, RESTRAINTS, AND OPPORTUNITIES
        11.1.1 OVERVIEW
        11.1.2 DRIVERS
        11.1.3 RESTRAINTS
        11.1.4 OPPORTUNITIES
    11.2   PORTERS FIVE FORCES ANALYSIS
        11.2.1 OVERVIEW
        11.2.2 BARGAINING POWER OF BUYERS
        11.2.3 BARGAINING POWER OF SUPPLIERS
        11.2.4 DEGREE OF COMPETITION
        11.2.5 THREAT OF NEW ENTRANTS
        11.2.6 THREAT OF SUBSTITUTES
    11.3    VALUE CHAIN ANALYSIS
12  APPENDIX